Woo YJ - Search Results

1

Oxygen-dependent quenching of phosphorescence used to characterize improved myocardial oxygenation resulting from vasculogenic cytokine therapy.

Hiesinger W, Vinogradov SA, Atluri P, Fitzpatrick JR 3rd, Frederick JR, Levit RD, McCormick RC, Muenzer JR, Yang EC, Marotta NA, MacArthur JW, Wilson DF, Woo YJ. Hiesinger W, et al. Among authors: woo yj. J Appl Physiol (1985). 2011 May;110(5):1460-5. doi: 10.1152/japplphysiol.01138.2010. Epub 2011 Feb 3. J Appl Physiol (1985). 2011. PMID: 21292844 Free PMC article.

2

Should Standard On-Pump Protamine Dosing Formulas Be Recalculated for Off-Pump Coronary Artery Bypass Grafting?

Woo YJ, Atluri P, Grand TJ, Hsu V, Gardner TJ. Woo YJ, et al. Heart Surg Forum. 2004 Jan 1;7(1):42-44. Heart Surg Forum. 2004. PMID: 14980850

3

Active thermoregulation improves outcome of off-pump coronary artery bypass.

Woo YJ, Atluri P, Grand TJ, Hsu VM, Cheung A. Woo YJ, et al. Asian Cardiovasc Thorac Ann. 2005 Jun;13(2):157-60. doi: 10.1177/021849230501300213. Asian Cardiovasc Thorac Ann. 2005. PMID: 15905346 Clinical Trial.

4

Creatine phosphate administration preserves myocardial function in a model of off-pump coronary revascularization.

Woo YJ, Grand TJ, Zentko S, Cohen JE, Hsu V, Atluri P, Berry MF, Taylor MD, Moise MA, Fisher O, Kolakowski S. Woo YJ, et al. J Cardiovasc Surg (Torino). 2005 Jun;46(3):297-305. J Cardiovasc Surg (Torino). 2005. PMID: 15956929

5

Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.

Woo YJ, Grand TJ, Berry MF, Atluri P, Moise MA, Hsu VM, Cohen J, Fisher O, Burdick J, Taylor M, Zentko S, Liao G, Smith M, Kolakowski S, Jayasankar V, Gardner TJ, Sweeney HL. Woo YJ, et al. J Thorac Cardiovasc Surg. 2005 Aug;130(2):321-9. doi: 10.1016/j.jtcvs.2004.11.041. J Thorac Cardiovasc Surg. 2005. PMID: 16077394 Free article.

6

Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction.

Cohen JE, Atluri P, Taylor MD, Grand TJ, Liao GP, Panlilio CM, Suarez EE, Zentko SE, Hsu VM, Berry MF, Smith MJ, Gardner TJ, Sweeney HL, Woo YJ. Cohen JE, et al. Among authors: woo yj. Heart Lung Circ. 2006 Apr;15(2):119-23. doi: 10.1016/j.hlc.2005.12.004. Epub 2006 Feb 15. Heart Lung Circ. 2006. PMID: 16469539

7

Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy.

Atluri P, Liao GP, Panlilio CM, Hsu VM, Leskowitz MJ, Morine KJ, Cohen JE, Berry MF, Suarez EE, Murphy DA, Lee WM, Gardner TJ, Sweeney HL, Woo YJ. Atluri P, et al. Among authors: woo yj. Ann Thorac Surg. 2006 May;81(5):1728-36. doi: 10.1016/j.athoracsur.2005.12.015. Ann Thorac Surg. 2006. PMID: 16631663

8

Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure.

Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Hsu VM, Cohen JE, Chaudhry HW. Woo YJ, et al. Circulation. 2006 Jul 4;114(1 Suppl):I206-13. doi: 10.1161/CIRCULATIONAHA.105.000455. Circulation. 2006. PMID: 16820573

9

Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy.

Kolakowski S Jr, Berry MF, Atluri P, Grand T, Fisher O, Moise MA, Cohen J, Hsu V, Woo YJ. Kolakowski S Jr, et al. Among authors: woo yj. J Card Surg. 2006 Nov-Dec;21(6):559-64. doi: 10.1111/j.1540-8191.2006.00296.x. J Card Surg. 2006. PMID: 17073953

10

Minimally invasive, robotic, and off-pump mitral valve surgery.

Woo YJ, Rodriguez E, Atluri P, Chitwood WR Jr. Woo YJ, et al. Semin Thorac Cardiovasc Surg. 2006 Summer;18(2):139-47. doi: 10.1053/j.semtcvs.2006.07.004. Semin Thorac Cardiovasc Surg. 2006. PMID: 17157235 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

579 results

Search Page